Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis

Zhuang, Huafeng; Wang, Pei‐wen; Li, Yi‐zhong; Lin, Johnson; Yao, Xuedong; Xu, Hao

doi:10.1111/os.12605

Cited by 24 publications

(21 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…If I 2 < 50%, the fixed effect model was used, otherwise, the random-effect model was adopted to calculate the pooled ORs. Pooled ORs and 95% CIs were calculated under the following genetic models: (1) allele, (2) recessive, (3) homozygous, (4) heterozygous, and (5) dominant. Publication bias was assessed by Begg's funnel plots.…”

Section: Discussionmentioning

confidence: 99%

“…Postmenopausal osteoporosis (PMO) caused by estrogen deficiency, is the most common type of primary osteoporosis which affects more than 40% of postmenopausal women [1][2][3]. As a typical senile disorder with decreasing bone-mineral density (BMD) and microstructural abnormality, PMO may lead to an increased risk for nonstress fractures [4]. Although, PMO is close related to estrogen levels following menopause, many factors, such as genetic elements had play important roles in the risk of osteoporosis [5,6].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association of ESR1 polymorphism rs2234693 and rs9340799 with Postmenopausal osteoporosis in a Chinese Population

Shu

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Postmenopausal osteoporosis (PMO) is the most common type of primary osteoporosis. ESR1 polymorphism rs2234693 and rs9340799 has been widely studied as a candidate gene associated with PMO, however, the findings were inconclusive. The present study aims to explore the relationship of ESR1 polymorphism rs2234693 and rs9340799 with PMO risk in a Chinese Han population. Methods A total of 230 unrelated PMO patients and 150 control were recruited. DNA of all participants was extracted from the peripheral blood samples and genotyped by Mass Array method. A meta-analysis of case control studies was also conducted to further elucidate the relationship of polymorphism with PMO. Results Our results revealed that there were no associations of the rs2234693 with PMO. However,GG genotype of rs9340799 was associated with a higher risk of PMO (OR=1.51, 95%CI:1.08-4.34, p=0.03), even adjusting for risk factors (OR=1.83, 95%CI: 1.12-5.04, p=0.04). Logistic regression analysis showed the dominant model was associated with a higher risk of PMO (OR = 2.07, 95%CI: 1.02-5.16, p=0.02) after correcting the risk factors (OR=2.14, 95%CI:1.12-5.64, p=0.04); In addition, the Meta-analysis results revealed that both two polymorphisms were not associated with PMO. Conclusion In conclusion,ESR1 polymorphism rs9340799 was associated with PMO, However, well designed study with larger sample sizes, is required to further elucidate these association.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Association of ESR1 polymorphism rs2234693 and rs9340799 with Postmenopausal osteoporosis in a Chinese Population

Shu

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The BMI was used to measure body fatness and health in an adult population. It is a neutral and reliable indicator, obtained by dividing a person's weight in kilograms by their height in meters squared 22 .…”

Section: Methodsmentioning

confidence: 99%

Exploring the Risk Factors for the Misdiagnosis of Osteonecrosis of Femoral Head: A Case‐Control Study

Tan

Jia

et al. 2020

Orthopaedic Surgery

View full text Add to dashboard Cite

The purpose of the present study was to evaluate the present situation and risk factors for the misdiagnosis of osteonecrosis of femoral head (ONFH), providing the basis for accurate diagnosis of ONFH. Methods: For this retrospective study, 1471 patients with ONFH were selected from the China Osteonecrosis of Femoral Head Database (CONFHD). These patients had been recruited between July 2016 and December 2018. According to whether or not they were misdiagnosed, the patients were divided into two groups, with 1168 cases (22-84 years old) included in the diagnosis group and 303 cases (21-80 years old) in the misdiagnosis group. Misdiagnosis was measured using the following criteria: (i) the patient had the same symptoms and signs, and the second diagnosis was not consistent with the initial diagnosis within 6 months; and (ii) the patient was admitted to a hospital participating in CONFHD and the previous diagnosis was inconsistent with the diagnosis given by the expert group. Comparisons of age, visual analogue scale for pain, and body mass index between the two groups were performed using a t-test. Gender, causes of ONFH, primary diseases requiring corticosteroids, methods of corticosteroid use, corticosteroid species, type of trauma, onset side of the disease, pain side, whether symptoms are hidden, and type of imaging examination at the initial visit were compared using the χ 2-test. Years of alcohol consumption, weekly alcohol consumption, and physician title at the initial visit were compared using a Mann-Whitney U-test. Furthermore, the statistically significant factors were evaluated using multiple regression analysis to investigate the risk factors of misdiagnosis. Results: A total of 303 patients (20.6%) were misdiagnosed: 118 cases were misdiagnosed as lumbar disc herniation, 86 cases as hip synovitis, 48 cases as hip osteoarthritis, 32 cases as rheumatoid arthritis, 11 cases as piriformis syndrome, 5 cases as sciatica, and 3 cases as soft-tissue injury. Whether symptoms are hidden

show abstract

“…The incidence of osteoporosis in postmenopausal women is reported to be between 30% and 55% 4 . With a worldwide aging population, the incidence of osteoporosis is rising year-on-year 5 . Normal bone metabolism requires a balance of bone resorption (osteoclast activities) and bone formation (osteoblast activities) 6 .…”

Section: Introductionmentioning

confidence: 99%

Ferric Ion Induction of Triggering Receptor Expressed in Myeloid Cells‐2 Expression and PI3K/Akt Signaling Pathway in Preosteoclast Cells to Promote Osteoclast Differentiation

Liu

Cao

et al. 2020

Orthopaedic Surgery

View full text Add to dashboard Cite

Objective Iron plays a significant role in multiple biological processes. The purpose of this study was to measure whether iron mediated osteoclast differentiation through regulation of triggering receptor expressed in myeloid cells‐2 (Trem‐2) expression and the PI3K/Akt signaling pathway. Methods The effects of six different concentrations of ferric ammonium citrate (FAC) (100, 80, 40, 20, 10 and 0 μmol/L) on RAW 264.7 cells proliferation were assessed by Cell Counting Kit‐8 (CCK‐8) gassay. Tartrate resistant acid phosphatase (TRAP) assay was performed to detect the effects of FAC on osteoclast formation. The expression of osteoclast differentiation‐related (TRAP, NFATc‐1, and c‐Fos) and Trem‐2 mRNA and proteins was analyzed by reverse transcription‐polymerase chain reaction and western blot, respectively. Si‐Trem‐2 was constructed and transfected to RAW264.7 to measure the effects of Trem‐2 on FAC‐mediated osteoclast formation. TRAP assay and osteoclast differentiation‐related gene analyses were further performed to identify the role of Trem‐2 in osteoclastogenesis. The Search Tool for the Retrieval of Interacting Genes (STRING) was used to explore the target genes of Trem‐2. Trem‐2‐related gene ontology and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were used for further in‐depth analysis. PI3K/Akt pathway‐related proteins were detected by immunofluorescence and western blot. Results In groups with FAC concentration of 10 (102.5 ± 3.1), 20 (100.5 ± 1.5), and 40 μmol/L (98.7 ± 3.1), compared with the control group (100.1 ± 2.2), cell viability was not significantly different from the control (P > 0.05). When the concentration of FAC exceeded 80 μmol/L, cell viability was significantly decreased (87.5 ± 2.8 vs 100.1 ± 2.2, P < 0.05). FAC promotes Trem‐2 expression and osteoclast differentiation in a dose‐response manner (P < 0.05). The number of osteoclast‐like cells was found to be reduced following transfection with the siRNA of Trem‐2 (42 ± 3 vs 30 ± 5, P < 0.05). We observed that most of Trem‐2 target genes are primarily involved in response to organic substance, regulation of reactive oxygen species metabolic process, and regulation of protein phosphorylation. The STRING database revealed that Trem‐2 directly target two gene nodes (Pik3ca and Pik3r1), which are key transcriptional cofactors of the PI3K/Akt signaling pathway. KEGG pathways include the “PI3K‐Akt signaling pathway,” the “thyroid hormone signaling pathway”, “prostate cancer,” the “longevity regulating pathway,” and “insulin resistance.” Expression of p‐PI3K and p‐Akt protein, measured by immunofluorescence and western blotting, was markedly increased in the FAC groups. Trem‐2 siRNA caused partial reduction of these two proteins (p‐PI3K and p‐Akt) compared to the FAC alone group. Conclusion The FAC promoted osteoclast differentiation through the Trem‐2‐mediated PI3K/Akt signaling pathway. However, its regulation osteoclastogenesis should be verified through further in vivo studies.

show abstract

Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis

Cited by 24 publications

References 19 publications

Association of ESR1 polymorphism rs2234693 and rs9340799 with Postmenopausal osteoporosis in a Chinese Population

Association of ESR1 polymorphism rs2234693 and rs9340799 with Postmenopausal osteoporosis in a Chinese Population

Exploring the Risk Factors for the Misdiagnosis of Osteonecrosis of Femoral Head: A Case‐Control Study

Ferric Ion Induction of Triggering Receptor Expressed in Myeloid Cells‐2 Expression and PI3K/Akt Signaling Pathway in Preosteoclast Cells to Promote Osteoclast Differentiation

Contact Info

Product

Resources

About